The effects of mTOR inhibition in ischemic stroke

With a global incidence of 9.5 million cases annually and 56 million disability-adjusted life-years, ischemic stroke is the primary cause of adult disability in developed countries. However, the significant successes in stroke trials have been in the field of reperfusion therapies for ischemic strok...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur: Schneider, AM
Awduron Eraill: Buchan, A
Fformat: Traethawd Ymchwil
Iaith:English
Cyhoeddwyd: 2022
Pynciau:

Eitemau Tebyg